Explore the full management transaction log of Aileron Therapeutics, Inc., a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was reported on 9 December 2024 (Acquisition). Among the most active insiders: UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO. Every trade is free.
6
Insider Decl.
0
Thresholds
€509
1 ops.
Buy Volume
€96,815
5 ops.
Sell Volume
34Σ signal
Buys €509€96,815 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.